Microgram-order ammonium perfluorooctanoate may activate mouse peroxisome proliferator-activated receptor α, but not human PPARα
Microgram-order ammonium perfluorooctanoate may activate mouse peroxisome proliferator-activated receptor α, but not human PPARα
复制标题
DOI:
10.1016/j.tox.2009.09.004
复制
发表时间:
2009-11-09
期刊:
影响因子:
4.5
通讯作者:
Nakajima, Tamie
中科院分区:
文献类型:
--
作者:
Nakamura, Toshiki;Ito, Yuki;Nakajima, Tamie
Perfluorooctanoic acid (PFOA) is a ligand for peroxisome proliferator-activated receptor (PPAR)alpha, which exhibits marked species differences in expression and function, especially between rodents and humans. We investigated the functional difference in PFOA response between mice and humans, using a humanized PPAR alpha transgenic mouse line. Three genotyped mice, 129/5v wild-type (mPPAR alpha), Ppar alpha-null mice and humanized PPAR alpha (hPPAR alpha) mice (8-week-old males) were divided into three groups: the first was treated with water daily for 2 weeks by gavage (control group), and the remaining two groups were treated with 0.1 and 0.3 mg/kg ammonium perflurooctanate (APFO), respectively, for 2 weeks by gavage. The APFO dosages used did not influence the plasma triglyceride or total cholesterol levels in any mouse line, but the high dose increased both hepatic lipid levels only in mPPAR alpha mice. APFO increased mRNA and/or protein levels of PPAR alpha target genes cytochrome P450 Cyp4a10, peroxisomal thiolase and bifunctional protein only in the liver of mPPAR alpha mice, but not in Ppar alpha-null or hPPAR alpha mice. This chemical also increased expression of mitochondrial very long chain acyl-CoA dehydrogenase only in the liver of mPPAR alpha mice. Taken together, human PPAR alpha may be less responsive to PFOA than that of mice when a relatively low dose is applied. This information may be very valuable in considering whether PFOA influences the lipid metabolism in humans. (c) 2009 Elsevier Ireland Ltd. All rights reserved.